Parkinson Disease and Antiparkinsonian Drugs

Author(s):  
Ashok E. Philip ◽  
George DeMaagd ◽  
M. O. Faruk Khan
Neurology ◽  
2017 ◽  
Vol 89 (2) ◽  
pp. 138-143 ◽  
Author(s):  
Ali H. Rajput ◽  
Michele L. Rajput ◽  
Leslie W. Ferguson ◽  
Alex Rajput

Objective:To identify the significance of baseline motor features to the lifelong prognostic motor subtypes in a Parkinson disease (PD) cohort.Methods:In a previous study of 166 PD cases, we observed different prognosis in tremor-dominant, akinetic-rigid, and mixed subtypes. This study includes the same cases, but we excluded 10 cases with symptoms of ≥15 years duration at baseline. Relative severity of tremor, bradykinesia/akinesia, and rigidity at baseline were evaluated as predictors of the motor subtypes, which are known to have different prognosis.Results:The most common motor subtype was mixed, followed by akinetic-rigid and then the tremor-dominant. Seventy cases were not receiving antiparkinsonian drugs at baseline. The prognostic subtypes could be predicted at baseline in 85% of all and in 91% of the treatment-naive cases. Sensitivity, specificity, and positive predictive values were strong for the mixed and the akinetic-rigid but weak for the tremor-dominant subtype.Conclusions:Our data show that motor profile at baseline can predict prognosis in most PD cases. These findings can be incorporated into clinical practice.


2011 ◽  
Author(s):  
D. Leo ◽  
M. J. Bourque ◽  
C. Kortleven ◽  
E. A. Fon ◽  
L. E. Trudeau

2020 ◽  
Vol 19 (6) ◽  
pp. 373-373
Author(s):  
Asher Mullard
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document